Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Dipna PharmachemBOM:543594 +9.64%66 Days Inventory is 136.38 as of Mar. 2026, which is 95% above its 10-year median of 69.93. GuruFocus rates BOM:543594 with a GF Score™ of 66/100 and a GF Value™ of ₹9.01 (Possible Value Trap). The stock has 9 warning signs investors should review. Among 493 Healthcare Providers & Services companies, Dipna Pharmachem ranks worse than 86.21% on this metric.
The historical rank and industry rank for Dipna Pharmachem's Days Inventory or its related term are showing as below:
BOM:543594'
s Days Inventory Range Over the Past 10 Years
Min: 35.91 Med: 69.93 Max: 111.95
Current: 111.52
During the past 7 years, Dipna Pharmachem's highest Days Inventory was 111.95. The lowest was 35.91. And the median was 69.93.
BOM:543594's Days Inventory is ranked worse than 86.21% of 493
companies
in the Healthcare Providers & Services industry
Industry Median: 29.15
vs BOM:543594: 111.52
Dipna Pharmachem's Days Inventory
declined
from Mar. 2025 (243.39) to Mar. 2026 (136.38).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Dipna Pharmachem's Inventory Turnover for the
six
months ended in Mar. 2026 was 1.34.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Dipna Pharmachem's Inventory-to-Revenue for the
six
months ended in Mar. 2026 was 0.73.
Dipna Pharmachem (BOM:543594) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Dipna Pharmachem's Inventory Turnover for the
six
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Dipna Pharmachem's Inventory to Revenue for the
six
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Dipna Pharmachem Days Inventory Related Terms
Dipna Pharmachem Days Inventory Historical Data
* Premium members only.
The historical data trend for Dipna Pharmachem's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dipna Pharmachem Days Inventory Competitor Comparison
For the Pharmaceutical Retailers subindustry, Dipna Pharmachem's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dipna Pharmachem Days Inventory vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Dipna Pharmachem's Days Inventory distribution charts can be found below:
* The bar in red indicates where Dipna Pharmachem's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dipna Pharmachem (BOM:543594) has a Days Inventory of 136.38 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Dipna Pharmachem and its competitors. This is 95% above median its historical median of 69.93. Over the past decade, Dipna Pharmachem's Days Inventory has ranged from 35.91 to 111.95. According to the industry distribution chart, Dipna Pharmachem ranks #425 out of 493 companies in the Healthcare Providers & Services industry, placing it in the top 86.2%.
Is Dipna Pharmachem's Days Inventory too high?
Dipna Pharmachem's current Days Inventory of 136.38 is 95% above median its 10-year median of 69.93. Over the past 10 years, this metric has ranged from a low of 35.91 to a high of 111.95. The Healthcare Providers & Services industry median Days Inventory is 29.15. Dipna Pharmachem's value of 136.38 is 367.9% above this industry median. Based on the distribution chart, Dipna Pharmachem ranks #425 out of 493 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Dipna Pharmachem has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Dipna Pharmachem's Days Inventory compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Dipna Pharmachem ranks #425 out of 493 companies for Days Inventory. This places Dipna Pharmachem in the lower half of its industry. The industry median Days Inventory is 29.15. Dipna Pharmachem's value of 136.38 is 367.9% above this benchmark. Historically, Dipna Pharmachem's own Days Inventory has ranged from 35.91 to 111.95 over the past decade. While the company's 10-year median is 69.93 vs. the industry median of 29.15, Dipna Pharmachem has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Healthcare Providers & Services company?
The median Days Inventory among Healthcare Providers & Services companies is 29.15, based on 493 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dipna Pharmachem's current Days Inventory of 136.38 is 367.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Dipna Pharmachem and its competitors. For the Healthcare Providers & Services industry, the median Days Inventory is 29.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dipna Pharmachem's current Days Inventory is 136.38, which is 95% above median its own 10-year median of 69.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dipna Pharmachem stock overvalued right now?
Based on GuruFocus' analysis, Dipna Pharmachem (BOM:543594) is currently considered Possible Value Trap. The stock's GF Value™ is ₹9.01, compared to a current price of ₹4.89 — trading 45.7% below its estimated fair value. The current Days Inventory is 136.38, which is 95% above median its 10-year median of 69.93 and 367.9% above the Healthcare Providers & Services industry median of 29.15. Dipna Pharmachem's overall GF Score™ is 66/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Dipna Pharmachem (BOM:543594), the current Days Inventory is 136.38 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dipna Pharmachem (BOM:543594) Overvalued in 2026?
Based on GuruFocus' analysis, Dipna Pharmachem stock appears to be undervalued.
The current stock price of ₹4.89 is trading 45.7% below its estimated GF Value™ of ₹9.01.
GuruFocus considers Dipna Pharmachem to be Possible Value Trap.
Key valuation signals for BOM:543594:
Days Inventory: 136.38 (95% above median its 10-year median of 69.93)
GF Value™: ₹9.01 vs. price of ₹4.89 (45.7% below fair value)
Industry Position: 367.9% above the Healthcare Providers & Services median (#425 of 493)
No single metric tells the full story. See the BOM:543594 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dipna Pharmachem Ltd is engaged in the trading and distribution of a wide range of pharmaceutical raw materials which is also known as APIs (Active Pharmaceutical Ingredients), Excipient and chemical formulation products. The company's product portfolio comprises of Hydrocortisone Acetate, Aceclofenac, Asprin, Levofloxacin, and others.
66GF Score
Get the complete analysis for BOM:543594
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543594 has been successfully added to your 
